X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4) 4
chemotherapy (3) 3
humans (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
bone marrow (2) 2
cancer (2) 2
elderly-patients (2) 2
female (2) 2
germany (2) 2
leukemia (2) 2
leukemia, myeloid, acute - drug therapy (2) 2
leukemia, myeloid, acute - mortality (2) 2
male (2) 2
middle aged (2) 2
mortality (2) 2
oncology (2) 2
risk factors (2) 2
stem-cell transplantation (2) 2
time factors (2) 2
transplants & implants (2) 2
abridged index medicus (1) 1
ac133 antigen - metabolism (1) 1
acute lymphoblastic b cell precursor leukemia (1) 1
acute lymphoblastic-leukemia (1) 1
acute myelogenous leukemia (1) 1
adult (1) 1
adult patients (1) 1
age factors (1) 1
aged (1) 1
aged, 80 and over (1) 1
aml (1) 1
analysis (1) 1
animals (1) 1
antibiotics, antineoplastic - therapeutic use (1) 1
antimetabolites, antineoplastic - therapeutic use (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
bcl2 (1) 1
bone-marrow (1) 1
cell line, tumor (1) 1
cell proliferation - drug effects (1) 1
chemotherapy, adjuvant (1) 1
classification (1) 1
clinical trials (1) 1
colon - cytology (1) 1
colorectal cancer (1) 1
colorectal neoplasms - drug therapy (1) 1
colorectal neoplasms - metabolism (1) 1
combination (1) 1
conferences (1) 1
cooperative-oncology-group (1) 1
council aml11 trial (1) 1
cytarabine (1) 1
cytarabine - administration & dosage (1) 1
cytarabine - therapeutic use (1) 1
daunorubicin - administration & dosage (1) 1
daunorubicin - therapeutic use (1) 1
development and progression (1) 1
disease progression (1) 1
disease-free survival (1) 1
dose cytarabine (1) 1
double-blind method (1) 1
double-hit (1) 1
extramedullary manifestation (1) 1
favorable prognosis (1) 1
features (1) 1
flt3 mutations (1) 1
fluorouracil - pharmacology (1) 1
gene expression profiling (1) 1
genetic aspects (1) 1
genetic research (1) 1
health aspects (1) 1
hematology (1) 1
hematology, oncology and palliative medicine (1) 1
hematopoietic stem cell transplantation (1) 1
heterocyclic compounds, 3-ring - pharmacology (1) 1
hypertension (1) 1
induction chemotherapy (1) 1
internal medicine (1) 1
internet (1) 1
intestinal mucosa - cytology (1) 1
kaplan-meier estimate (1) 1
leukemia, myeloid, acute - diagnosis (1) 1
lymphoma (1) 1
lymphomas (1) 1
medical colleges (1) 1
medical prognosis (1) 1
medicine & public health (1) 1
medicine, general & internal (1) 1
meetings (1) 1
mice (1) 1
mice, inbred nod (1) 1
mice, scid (1) 1
microrna-expression signatures (1) 1
mitoxantrone - administration & dosage (1) 1
mtor (1) 1
multivariate analysis (1) 1
myc (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 16, pp. 1691 - 1699
Summary Background Preclinical data and results from non-randomised trials suggest that the multikinase inhibitor sorafenib might be an effective drug for the... 
Hematology, Oncology and Palliative Medicine | AML | ONCOLOGY | ACUTE MYELOGENOUS LEUKEMIA | BONE-MARROW | CLASSIFICATION | FLT3 MUTATIONS | CYTARABINE | STEM-CELL TRANSPLANTATION | COMBINATION | ELDERLY-PATIENTS | CHEMOTHERAPY | Niacinamide - analogs & derivatives | Recurrence | Age Factors | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Protein Kinase Inhibitors - adverse effects | Transplantation, Homologous | Neoadjuvant Therapy - mortality | Time Factors | Phenylurea Compounds - adverse effects | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Chemotherapy, Adjuvant | Daunorubicin - therapeutic use | Double-Blind Method | Risk Factors | Kaplan-Meier Estimate | Niacinamide - adverse effects | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Treatment Outcome | Disease Progression | Leukemia, Myeloid, Acute - mortality | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Leukemia, Myeloid, Acute - diagnosis | Antibiotics, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - adverse effects | Protein Kinase Inhibitors - therapeutic use | Germany | Antimitotic agents | Clinical trials | Chemotherapy | Antineoplastic agents | Standards | Cancer
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9757, pp. 2000 - 2008
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 9/2016, Volume 23, Issue 9, pp. 2849 - 2857
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.